# Medication Interaction Design

## Purpose

Define the planned medication gameplay interaction logic for ACE Critical Care.

## Scope

This document belongs to WP-M0-03 Medical System Design.

## Design Philosophy

Medication gameplay should support meaningful treatment decisions while remaining understandable and gameplay-focused.

The system prioritizes:

- Clear treatment purpose
- Readable medical effects
- Multiplayer-safe processing
- Explicit interaction logic

## Planned Medication Areas

### Medication Administration

The medication system plans to support controlled administration workflows.

Medication usage should remain explicit and interaction-driven.

### Medication Effects

Medication logic may influence:

- Consciousness state
- Circulation state
- Respiratory state
- Cardiac state
- Treatment progression

### Medication Interactions

Medication systems should support interaction with:

- Trauma systems
- Breathing systems
- Monitoring systems
- Circulatory systems

Medication systems should avoid hidden uncontrolled side effects.

## Planned Gameplay Priorities

The medication system should support:

- Decision-based treatment gameplay
- Escalation of care
- Monitoring-driven reassessment
- Team-based medical workflows

## Planned Processing Philosophy

Medication effects should remain:

- Server-authoritative
- Explicitly processed
- Replication-safe
- Predictable and debuggable

Avoid unclear background processing.

## Multiplayer Considerations

Critical medication processing remains server-authoritative.

Clients may display medication feedback and UI state.

## Risks

### State Coupling

Medication effects may become difficult to maintain if too many systems directly modify each other.

### Replication Overhead

Frequent medication-related updates may increase network traffic.

### Gameplay Complexity

Overly detailed pharmacology may negatively impact gameplay pacing.

### Hidden Logic Risk

Implicit medication interactions may reduce debuggability.

## Current Status

Planning only.

No runtime medication implementation is performed during WP-M0-03.